Article
Analysis of CDKN1A polymorphisms: markers of cancer susceptibility?
Cancer genetics and cytogenetics - 15 Apr 2003
Rodrigues Flávia C C, Kawasaki-Oyama Rosa S, Fo José F Gois, Ukuyama Erica E, Antonio João Roberto, Bozola Antonio R, Romeiro Janaina G, Rahal Paula, Tajara Eloiza H
Abstract excerpt
The CDKN1A (TP21) gene encodes a 21-kD protein that is a critical downstream mediator of wild-type TP53 and an important regulator of the cell cycle. Failure in the function of this gene would be expected to result in abnormal cell proliferation and transformation. Tumor-associated mutations of the coding region of the TP21 are rare. On the other hand, some TP21 polymorphisms have been identified and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
